scispace - formally typeset
M

Min Xu

Researcher at Chinese Academy of Sciences

Publications -  139
Citations -  2459

Min Xu is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 25, co-authored 122 publications receiving 1832 citations. Previous affiliations of Min Xu include Nanjing Normal University & Griffith University.

Papers
More filters
Journal ArticleDOI

Intensive human impacts drive the declines in heterogeneity of diatom communities in shallow lakes of East China

TL;DR: In this article , the authors combine paleolimnology and network science to propose a heterogeneity index (H) to measure community successions by linking long-term changes in community structure with environmental stress.
Journal ArticleDOI

Essential oil of lemon myrtle (Backhousia citriodora) induces S-phase cell cycle arrest and apoptosis in HepG2 cells.

TL;DR: In this article , the authors found that the essential oil of lemon myrtle (LMEO) showed anti-cancer activity in vitro, and they initially explored its mechanism of action.
Journal ArticleDOI

Study on Chemical Constituents of Panax notoginseng Leaves

TL;DR: Panax notoginseng leaves were isolated and purified by different chromatographic methods, and the structures of 1-22 compounds were elucidated mainly through comprehensive analyses of spectroscopic data as mentioned in this paper .

Source Identification and Ecological Risk of Potentially Harmful Trace Elements in Lacustrine Sediments from the Middle and Lower Reaches of Huaihe River

TL;DR: In this article , Zhao et al. investigated the source and source identification of potentially harmful trace elements (PHTEs) from the middle and lower reaches of Huaihe River.
Journal ArticleDOI

A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo

TL;DR: Oral administration of PAC5 eliminated HBV cccDNA and reduced the large antigen load in distinct mouse models of HBV infection and indicates that PAC5 is a novel small-molecule agonist of hnRNPA2B1, which may have a role in dealing with emerging infectious diseases now and in the future.